Sarcomatrix Therapeutics
Manufacturing · Nevada, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
450 Sinclair St, Reno, Nevada, 89501, Un...Phone Number
(775) 525-1795Website
www.sarcomatrix.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Sarcomatrix Therapeutics
Sarcomatrix Therapeutics is a biopharmaceutical company focused on developing oral therapies for Duchenne muscular dystrophy and related neuromuscular disorders. The company's mission is to deliver effective, scalable treatments that can be broadly accessible to patients and families worldwide.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sarcomatrix Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Sarcomatrix Therapeutics has new funding data
Congratulate Masked Content for being promoted to Masked Content at Sarcomatrix Therapeutics
Click to see if Sarcomatrix Therapeutics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Sarcomatrix Therapeutics launches new products
Check if Sarcomatrix Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Check out if Sarcomatrix Therapeutics is spiking on competitors!
Sarcomatrix Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Sarcomatrix Therapeutics recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Sarcomatrix Therapeutics
Compare insights from companies similar to Sarcomatrix Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Sarcomatrix Therapeutics
<$5M
11-50
Private
<$5M
2022
N/A
Company Profile Activity
Activity Insights
Sarcomatrix Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Sarcomatrix Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Sarcomatrix Therapeutics.
Sarcomatrix Therapeutics financials insights
Gather financial insights about Sarcomatrix Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Other Financing Round
$300K
Sarcomatrix Therapeutics Tech Stack
A closer look at the technologies used by Sarcomatrix Therapeutics
See more technologies
Most Recent Scoops
Funding
Funding
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Person-Based
Person-Based
Person-Based
Sarcomatrix Therapeutics News & Media
Sarcomatrix Renews United States Orphan Drug Designation for LAMA2-Related Muscular Dystrophy Program
RENO, NV, UNITED STATES, April 9, 2025 /EINPresswire.com/ -- Sarcomatrix Therapeutics, a privately held biopharmaceutical company advancing transformative therapies for severe muscle diseases, today announced the renewal of its Orphan Drug Designation ( …Sarcomatrix Therapeutics to Present Advances in Muscle Disease Drug Development at 2025 BIO CEO & Investor Conference
Company Prepares for Phase 1 Clinical Trials of Lead Candidate S-969 in 2025 RENO, NV, UNITED STATES, February 7, 2025 /EINPresswire.com/ -- Sarcomatrix Therapeutics Corp., a clinical-stage biotechnology company focused on revolutionizing treatments for …Sarcomatrix Joins Biotechnology Innovation Organization to Drive Breakthroughs in Muscle Disease Therapies
RENO, NV, UNITED STATES, January 23, 2025 /EINPresswire.com/ -- Sarcomatrix Therapeutics, a pioneering biotechnology company dedicated to developing innovative therapies for muscle diseases and rare conditions, proudly announces its membership in the …Sarcomatrix to Present at Three Major Events During JPM Week 2025 in San Francisco
RENO, NV, UNITED STATES, January 6, 2025 /EINPresswire.com/ -- Reno, NV – January 6, 2025 – Sarcomatrix Therapeutics, a pioneering biotech company advancing innovative therapies for muscle diseases, is proud to announce its participation in three high- …
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sarcomatrix Therapeutics
Sign Up For FreeTo access detailed company insights
Sarcomatrix Therapeutics is a biopharmaceutical company focused on developing oral therapies for Duchenne muscular dystrophy and related neuromuscular disorders. The company's mission is to deliver effective, scalable treatments that can be broadly accessible to patients and families worldwide.... Read More
